Specialty Enzymes Market

Specialty Enzymes Market by Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases, and Other enzymes), Source, Application (pharmaceuticals, Research & Biotechnology, Diagnostics, and Biocatalysts), Form, and Region - Global Forecast to 2025

Report Code: FB 2276 Apr, 2020, by marketsandmarkets.com
COVID-19

Get in-depth analysis of the COVID-19 impact on the Specialty Enzymes Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Specialty Enzymes Market

Request For Special Pricing

[180 Pages Report] According to MarketsandMarkets, the specialty enzymes market is estimated to be valued at USD 4.4 billion in 2019 and is projected to reach USD 6.6 billion by 2025, recording a CAGR of 6.9% in terms of value. The rise in demand for non-harmful biological catalysts in pharmaceuticals & diagnostics led to the growth of the specialty enzymes market. In addition, the advancement of tools to optimize pharmaceutical production and quality concerns among people have increased the usage of specialty enzymes. Factors such as the multifunctional benefits of specialty enzymes across various applications and technological innovations to reduce the consumption of chemical catalysts are contributing to the growth of the specialty enzyme market.

Specialty Enzymes Market

By type, the polymerases & nucleases segment is projected to account for the largest share in the specialty enzymes market during the forecast period

The polymerases & nucleases segment is projected to dominate the market during the forecast period. Polymerases & nucleases are used in specialty applications, such as pharmaceuticals, research & biotechnology, diagnostics, and biocatalysts. Polymerases & nucleases have been grouped together as they both work on nucleic acid polymers such as ribonucleic acid (RNA) and deoxyribonucleic acid (DNA), and are commonly used in similar applications. These types of enzymes catalyze the synthesis of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) polymers, as they are essential for all nucleic acid processing, including replication, repair, recombination, and transcription.

By application, the pharmaceuticals segment accounted for the largest market size in the specialty enzymes market during the forecast period

The demand for specialty enzymes is increasing significantly due to the increasing application of enzymes in the pharmaceutical industry. Specialty enzyme usage in the pharmaceutical industry is mainly for drug manufacture, disease diagnostics, or as therapy. Increasing incorporation of enzymes in therapies for diseases such as cancer, cardiovascular diseases, lysosomal storage disorders, and pain and inflammation management, among others, is a factor that fuels market demand.

Specialty Enzymes Market

North America is projected to account for the largest market share during the forecast period

In 2018, North America accounted for the largest market share in the specialty enzymes market. Technological advancements in this region have made enzymes available for a wide range of applications, and this segment is estimated to drive the growth of the market in the region. This region is projected to be the largest market due to the development of novel and superior performing products and global industrialization. The pharmaceutical industry in this region is also witnessing a rise in the usage of enzymes. The US is the dominant country, and the market in this region has reached its maturity. These factors are projected to contribute to the growth of the North American market.

Key Market Players:

Key players in the specialty enzymes market include BASF (Germany), DuPont (US), Roche Holding (Switzerland), Novozymes (Denmark), DSM (Netherlands), Sanofi (France), and Codexis (US).

Scope of the report

Report Metric

Details

Market size estimation

2017–2025

Base year considered

2018

Forecast period considered

2019–2025

Units considered

Value (USD)

Segments covered

Type, source, applications, form, and region

Regions covered

North America, Europe, Asia Pacific, and RoW

Companies studied

  • BASF (Germany)
  • Novozymes (Denmark)
  • Roche Holding (Switzerland)
  • DuPont (US)
  • Codexis (US)
  • Dyadic International (US)
  • Advanced Enzymes (India)
  • Amano Enzymes (Japan)
  • Sanofi (France)
  • Biocatalysts (UK)
  • Enzyme Supplies (UK)
  • BBI Solutions (UK)
  • Specialty Enzymes & Probiotics (US)
  • Amicogen (South Korea)
  • Antozyme Biotech (India)
  • Enzyme Development Corporation (US)
  • Nagase & Co. Ltd. (Japan)
  • Sekisui Diagnostics (US)
  • Merck (Germany)
  • Biovet (Bulgaria)

This research report categorizes the specialty enzymes market based on type, source, application, form, and region.

Target Audience:

  • Enzyme manufacturing companies and government organizations
  • Service providing company officials
  • Government and research organizations
  • Research officers
  • CEOs and vice presidents
  • Marketing directors
  • Product innovation directors and related key executives from manufacturing companies and organizations operating in the market
  • Manufacturing and marketing companies

By Type

  • Carbohydrases
    • Amylases
    • Cellulases
    • Other carbohydrases
  • Proteases
  • Lipases
  • Polymerases & nucleases
  • Other enzymes

By Source

  • Microorganisms
  • Plants
  • Animals

By Application

  • Pharmaceuticals
  • Research & biotechnology
  • Diagnostics
  • Biocatalysts

By Form

  • Liquid
  • Dry

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)
    • Brazil
    • Argentina
    • South Africa
    • Others in RoW

Recent Developments

  • DuPont Nutrition & Biosciences launched its industry-leading OPTIMASE portfolio. This portfolio contains bio-based enzymes, which will be used for the cleaning of medical instruments. The product range is aimed at high performance and reduction in enzyme stabilizing ingredients, while also saving space and cost.
  • Roche Holding (Switzerland) entered into an agreement with Codexis (US) for providing enzymes. Codexis will supply EvoT4 DNA ligase to Roche. EvoT4 DNA ligase is a high-performance molecular diagnostic enzyme.
  • BASF (Germany) entered into a cooperation agreement with Conagen (US), a leader in biotechnology research. Conagen has strong R&D capabilities for fermented ingredients. This decision will enable BASF to serve the market with one of the aroma ingredients with the highest demand—natural vanillin.
  • Novozymes (Denmark) expanded its presence in East Africa. This allowed the company to meet consumer needs for enzyme products in the region.
  • Sanofi (France) opened its first digitally enabled manufacturing facility in Framingham, Massachusetts. The new manufacturing facility has the technology of connecting the production process to R&D. This will improve the commercialization of new medicines.

Key Questions Addressed by the Report

  • What are the growth opportunities in the specialty enzymes market?
  • What are the major applications of enzymes across different industries?
  • What are the key factors affecting market dynamics?
  • What are some of the significant challenges and restraints that the industry faces?
  • Which are the key players operating in the market, and what initiatives have they undertaken over the past few years?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 19)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 STUDY SCOPE
           1.3.1 REGIONS COVERED
           1.3.2 PERIODIZATION CONSIDERED
    1.4 CURRENCY CONSIDERED
    1.5 VOLUME UNIT CONSIDERED
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 24)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key Data from Secondary Sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key Data from Primary Sources
    2.2 FACTOR ANALYSIS
           2.2.1 INTRODUCTION
           2.2.2 DEMAND-SIDE ANALYSIS
           2.2.3 SUPPLY-SIDE ANALYSIS
    2.3 MARKET SIZE ESTIMATION
           2.3.1 APPROACH ONE (BASED ON APPLICATION, BY REGION)
           2.3.2 APPROACH TWO (BASED ON THE GLOBAL MARKET)
    2.4 DATA TRIANGULATION
    2.5 RESEARCH ASSUMPTIONS
    2.6 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 37)

4 PREMIUM INSIGHTS (Page No. - 42)
    4.1 ATTRACTIVE OPPORTUNITIES IN THE SPECIALTY ENZYMES MARKET
    4.2 SPECIALTY ENZYMES MARKET: MAJOR REGIONAL SUBMARKETS
    4.3 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION AND KEY COUNTRY
    4.4 MARKET, BY TYPE AND REGION
    4.5 MARKET, BY APPLICATION

5 MARKET OVERVIEW (Page No. - 47)
    5.1 INTRODUCTION
    5.2 YC-YCC SHIFT
    5.3 ROLE OF SPECIALTY ENZYMES IN COMBATING THE COVID-19 (CORONAVIRUS) PANDEMIC
           5.3.1 BROAD-SPECTRUM ANTIVIRAL ADVANCEMENTS TO COMBAT CORONAVIRUS
                    5.3.1.1 ADP-ribosylation-based developments could be a potential vaccine component
                    5.3.1.2 Real-time reverse-transcription-polymerases chain reaction assay for COVID-19 has been developed and used in clinics
    5.4 VALUE CHAIN
    5.5 MARKET DYNAMICS
           5.5.1 DRIVERS
                    5.5.1.1 Rise in Demand for Non-harmful Biological Catalysts in Pharmaceuticals & Diagnostics
                    5.5.1.2 Advanced Tools to Optimize Pharmaceutical Production
           5.5.2 RESTRAINTS
                    5.5.2.1 Lack of Harmonization in the Regulatory Framework
                    5.5.2.2 High Adoption Costs involved for Small & Medium Enterprises
           5.5.3 OPPORTUNITIES
                    5.5.3.1 Alternative to Chemical Catalysts
                    5.5.3.2 Technological Innovations and Wide Industry Scope
                    5.5.3.3 Launching Enzymes with Long Shelf life
                               5.5.3.3.1 Encapsulation to enhance shelf life
           5.5.4 CHALLENGES
                    5.5.4.1 High Raw Material Costs Limiting Enzyme Usage
                    5.5.4.2 Concern Over Quality of Enzymes Used in Pharmaceuticals & Diagnostics

6 PATENT ANALYSIS (Page No. - 57)
    6.1 INTRODUCTION

7 SPECIALTY ENZYMES MARKET, BY TYPE (Page No. - 62)
    7.1 INTRODUCTION
    7.2 CARBOHYDRASES
           7.2.1 AMYLASES
           7.2.2 CELLULASES
           7.2.3 OTHER CARBOHYDRASES
    7.3 PROTEASES
           7.3.1 COMPETENT CHARACTERISTIC TO HYDROLYZE THE PROTEINS IS USED IN DIAGNOSTICS TO REVERSE THE PROGRESSION OF THE DISEASE
    7.4 LIPASES
           7.4.1 RISE IN DEMAND AMONG PHARMACEUTICAL MANUFACTURERS AS LIPASES ADMINISTRATE ENZYME DEFICIENCIES IN HUMANS
    7.5 POLYMERASES & NUCLEASES
           7.5.1 POLYMERASES & NUCLEASES FORM AN ESSENTIAL PART FOR ALL NUCLEIC ACID PROCESSES
    7.6 OTHER ENZYMES
           7.6.1 FUNCTIONAL BENEFITS IN VARIOUS APPLICATIONS HAVE BEEN DRIVING THE MARKET FOR OTHER ENZYMES

8 SPECIALTY ENZYMES MARKET, BY APPLICATION (Page No. - 73)
    8.1 INTRODUCTION
    8.2 PHARMACEUTICALS
           8.2.1 ENZYMES ACT AS AN ALTERNATIVE TO TRADITIONAL ANTIBIOTICS
    8.3 RESEARCH & BIOTECHNOLOGY
           8.3.1 USE OF ENZYMES IN DNA SEQUENCING REDUCES THE COST FOR SEQUENCING TECHNIQUES
    8.4 DIAGNOSTICS
           8.4.1 DIAGNOSING LIFE-THREATENING DISEASES AT AN INITIAL STAGE DRIVES THE DEMAND FOR SPECIALTY ENZYMES
    8.5 BIOCATALYSTS
           8.5.1 BIOCATALYSIS IS A PROMISING TECHNOLOGY IN WASTE MATERIAL TREATMENT

9 SPECIALTY ENZYMES MARKET, BY SOURCE (Page No. - 81)
    9.1 INTRODUCTION
    9.2 MICROORGANISMS
           9.2.1 HUGE PRODUCTION IN LESSER TIME BOOSTS THE INDUSTRIAL USAGE OF MICROBIAL ENZYMES
    9.3 PLANTS
           9.3.1 PLANT-BASED ENZYMES THRIVE OVER A WIDE RANGE OF TEMPERATURES
    9.4 ANIMALS
           9.4.1 BEING TEMPERATURE-SENSITIVE DISCOURAGES THE INDUSTRIAL USAGE OF ANIMAL-BASED ENZYMES

10 SPECIALTY ENZYMES MARKET, BY FORM (Page No. - 86)
     10.1 INTRODUCTION
     10.2 LIQUID
             10.2.1 EASE OF USE IN THE DIAGNOSTIC INDUSTRY BOOSTS THE USAGE OF THE LIQUID FORM
     10.3 DRY
             10.3.1 DRY FORM ENABLES A BETTER ACCURACY OF DOSAGES

11 SPECIALTY ENZYMES MARKET, BY REGION (Page No. - 88)
     11.1 INTRODUCTION
     11.2 NORTH AMERICA
             11.2.1 US
                        11.2.1.1 Increasing awareness among manufacturers pertaining to the enhanced product quality with the usage of enzymes to drive the market growth in the US
             11.2.2 CANADA
                        11.2.2.1 Enzymes usage has witnessed an increase in demand in cancer diagnosis
             11.2.3 MEXICO
                        11.2.3.1 Enzymes can be used in diagnostics to detect the changes in the substrate concentrations
     11.3 EUROPE
             11.3.1 ITALY
                        11.3.1.1 Rise in production in the pharmaceutical industry could increase the demand for specialty enzymes
             11.3.2 GERMANY
                        11.3.2.1 Rise in research & development involved in the pharmaceutical industry drives the demand for enzymes
             11.3.3 FRANCE
                        11.3.3.1 Rise in clinical developments would impact the French biotechnology industry and increase the usage of specialty enzymes
             11.3.4 SPAIN
                        11.3.4.1 Spanish government’s emphasis on developments in the pharmaceutical industry resulting in boosting the enzymes market
             11.3.5 UK
                        11.3.5.1 Enzymes used in the drug cloning technique could boost the market for specialty enzymes
             11.3.6 REST OF EUROPE
                        11.3.6.1 Growth in the pharmaceutical industry in most European countries driving the specialty enzymes market
     11.4 ASIA PACIFIC
             11.4.1 CHINA
                        11.4.1.1 Technical advancements augmenting the demand for specialty enzymes in China
             11.4.2 INDIA
                        11.4.2.1 The rising demand in the pharmaceutical industry would boost the specialty enzymes market
             11.4.3 JAPAN
                        11.4.3.1 Growing biotechnology advancements in Japan would augment the demand for specialty enzymes
             11.4.4 AUSTRALIA & NEW ZEALAND
                        11.4.4.1 Favorable government regulations would increase biotechnology advancements, which would result in the rise in specialty enzymes usage
             11.4.5 REST OF ASIA PACIFIC
                        11.4.5.1 Developing countries in the Asia Pacific region present immense scope for the enzymes industry
     11.5 REST OF THE WORLD
             11.5.1 BRAZIL
                        11.5.1.1 The emerging pharmaceutical industry in Brazil driving the demand for enzymes
             11.5.2 ARGENTINA
                        11.5.2.1 Technological pharmaceutical advancements would boost the market for enzymes
             11.5.3 SOUTH AFRICA
                        11.5.3.1 Rising demand for generic medicines boosts growth in the South African pharmaceutical industry
             11.5.4 OTHERS IN ROW
                        11.5.4.1 Biotechnological advancements in African nations drive the market for specialty enzymes

12 COMPETITIVE LANDSCAPE (Page No. - 127)
     12.1 INTRODUCTION
     12.2 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET)
             12.2.1 VISIONARY LEADERS
             12.2.2 DYNAMIC DIFFERENTIATORS
             12.2.3 INNOVATORS
             12.2.4 EMERGING COMPANIES
     12.3 RANKING OF KEY PLAYERS, 2018
     12.4 STRENGTH OF PRODUCT PORTFOLIO (OVERALL MARKET)
     12.5 BUSINESS STRATEGY EXCELLENCE (OVERALL MARKET)
     12.6 COMPETITIVE SCENARIO
             12.6.1 EXPANSIONS & INVESTMENTS
             12.6.2 AGREEMENTS, COLLABORATIONS, AND JOINT VENTURES
             12.6.3 NEW PRODUCT LAUNCHES
             12.6.4 ACQUISITIONS
     12.7 COMPETITIVE LEADERSHIP MAPPING (START-UP/SME)
             12.7.1 PROGRESSIVE COMPANIES
             12.7.2 STARTING BLOCKS
             12.7.3 RESPONSIVE COMPANIES
             12.7.4 DYNAMIC COMPANIES
     12.8 STRENGTH OF PRODUCT PORTFOLIO (STARTUP/SME)
     12.9 BUSINESS STRATEGY EXCELLENCE (STARTUP/SME)

13 COMPANY PROFILES (Page No. - 139)
(Business overview, Products offered, Recent Developments, SWOT analysis, MNM view)* 
     13.1 BASF
     13.2 NOVOZYMES
     13.3 ROCHE HOLDING
     13.4 DUPONT
     13.5 CODEXIS
     13.6 DYADIC INTERNATIONAL
     13.7 ADVANCED ENZYMES
     13.8 AMANO ENZYME
     13.9 SANOFI
     13.10 BIOCATALYSTS
     13.11 ENZYME SUPPLIES
     13.12 BBI SOLUTIONS
     13.13 SPECIALTY ENZYMES & PROBIOTICS
     13.14 AMICOGEN
     13.15 ANTOZYME BIOTECH
     13.16 ENZYME DEVELOPMENT CORPORATION
     13.17 NAGASE & CO. LTD.
     13.18 SEKISUI DIAGNOSTICS
     13.19 MERCK KGAA
     13.20 BIOVET
*Details on Business overview, Products offered, Recent Developments, SWOT analysis, MNM view might not be captured in case of unlisted companies. 

14 APPENDIX (Page No. - 172)
     14.1 DISCUSSION GUIDE
     14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     14.3 AVAILABLE CUSTOMIZATIONS
     14.4 RELATED REPORTS
     14.5 AUTHOR DETAILS


LIST OF TABLES (110 Tables)

TABLE 1 USD EXCHANGE RATES CONSIDERED, 2014–2019
TABLE 2 SPECIALTY ENZYMES MARKET SNAPSHOT, 2019 VS. 2025
TABLE 3 PATENTS PERTAINING TO ENZYMES, 2017–2020
TABLE 4 SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 5 SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (TON)
TABLE 6 CARBOHYDRASES MARKET SIZE, BY REGION, 2017–2025 (USD MILLION)
TABLE 7 CARBOHYDRASES MARKET SIZE, BY SUBTYPE, 2017–2025 (USD MILLION)
TABLE 8 CARBOHYDRASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 9 AMYLASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 10 CELLULASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 11 OTHER CARBOHYDRASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 12 PROTEASES MARKET SIZE, BY REGION, 2017–2025 (USD MILLION)
TABLE 13 PROTEASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 14 LIPASES MARKET SIZE, BY REGION, 2017–2025 (USD MILLION)
TABLE 15 LIPASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 16 POLYMERASES & NUCLEASES MARKET SIZE, BY REGION, 2017–2025 (USD MILLION)
TABLE 17 POLYMERASES & NUCLEASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 18 OTHER ENZYMES MARKET SIZE, BY REGION, 2017–2025 (USD MILLION)
TABLE 19 OTHER ENZYMES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 20 MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 21 MARKET SIZE IN PHARMACEUTICALS, BY REGION, 2017–2025 (USD MILLION)
TABLE 22 MARKET SIZE IN PHARMACEUTICALS, BY TYPE, 2017–2025 (USD MILLION)
TABLE 23 MARKET SIZE IN RESEARCH & BIOTECHNOLOGY, BY REGION, 2017–2025 (USD MILLION)
TABLE 24 SPECIALTY ENZYMES MARKET SIZE IN RESEARCH & BIOTECHNOLOGY, BY TYPE, 2017–2025 (USD MILLION)
TABLE 25 SPECIALTY ENZYMES MARKET SIZE IN DIAGNOSTICS, BY REGION, 2017–2025 (USD MILLION)
TABLE 26 MARKET SIZE IN DIAGNOSTICS, BY TYPE, 2017–2025 (USD MILLION)
TABLE 27 MARKET SIZE IN BIOCATALYSTS, BY REGION, 2017–2025 (USD MILLION)
TABLE 28 MARKET SIZE IN BIOCATALYSTS, BY TYPE, 2017–2025 (USD MILLION)
TABLE 29 MARKET SIZE, BY SOURCE, 2017–2025 (USD MILLION)
TABLE 30 MICROORGANISM-BASED MARKET SIZE, BY REGION, 2017–2025 (USD MILLION)
TABLE 31 PLANT-BASED MARKET SIZE, BY REGION, 2017–2025 (USD MILLION)
TABLE 32 ANIMAL-BASED MARKET SIZE, BY REGION, 2017–2025 (USD MILLION)
TABLE 33 SPECIALTY ENZYMES MARKET SIZE, BY REGION, 2017–2025 (USD MILLION)
TABLE 34 NORTH AMERICA: MARKET SIZE, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 35 NORTH AMERICA: MARKET SIZE FOR PHARMACEUTICALS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: MARKET SIZE FOR RESEARCH & BIOTECHNOLOGY, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: MARKET SIZE FOR DIAGNOSTICS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 38 NORTH AMERICA: MARKET SIZE FOR BIOCATALYSTS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 39 NORTH AMERICA: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 40 NORTH AMERICA: MARKET SIZE, BY TYPE, 2017–2025 (TON)
TABLE 41 NORTH AMERICA: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 42 NORTH AMERICA: ENZYMES MARKET SIZE, BY SOURCE, 2017–2025 (USD MILLION)
TABLE 43 US: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 44 US: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 45 CANADA: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 46 CANADA: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 47 CANADA: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 48 MEXICO: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 49 MEXICO: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 50 EUROPE: MARKET SIZE, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 51 EUROPE: MARKET SIZE FOR PHARMACEUTICALS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 52 EUROPE: MARKET SIZE FOR RESEARCH & BIOTECHNOLOGY, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 53 EUROPE: SPECIALTY ENZYMES MARKET SIZE FOR DIAGNOSTICS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 54 EUROPE: SPECIALTY ENZYMES MARKET SIZE FOR BIOCATALYSTS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 55 EUROPE: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 56 EUROPE: MARKET SIZE, BY TYPE, 2017–2025 (TONS)
TABLE 57 EUROPE: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 58 EUROPE: ENZYMES MARKET SIZE, BY SOURCE, 2017–2025 (USD MILLION)
TABLE 59 ITALY: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 60 ITALY: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 61 GERMANY: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 62 GERMANY: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 63 FRANCE: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 64 FRANCE: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 65 SPAIN: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 66 SPAIN: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 67 UK: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 68 UK: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 69 REST OF EUROPE: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 70 REST OF EUROPE: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 71 ASIA PACIFIC: MARKET SIZE, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 72 ASIA PACIFIC: MARKET SIZE FOR PHARMACEUTICALS, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 73 ASIA PACIFIC: MARKET SIZE FOR RESEARCH & BIOTECHNOLOGY, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 74 ASIA PACIFIC: MARKET SIZE FOR DIAGNOSTICS, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 75 ASIA PACIFIC: MARKET SIZE FOR BIOCATALYSTS, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 76 ASIA PACIFIC: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 77 ASIA PACIFIC: MARKET SIZE, BY TYPE, 2017–2025 (TONS)
TABLE 78 ASIA PACIFIC: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 79 ASIA PACIFIC: ENZYMES MARKET SIZE, BY SOURCE, 2017–2025 (USD MILLION)
TABLE 80 CHINA: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 81 CHINA: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 82 INDIA: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 83 INDIA: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 84 JAPAN: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 85 JAPAN: SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 86 AUSTRALIA & NEW ZEALAND: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 87 AUSTRALIA & NEW ZEALAND: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 88 REST OF ASIA PACIFIC: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 89 REST OF ASIA PACIFIC: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 90 ROW: MARKET SIZE, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 91 ROW: MARKET SIZE FOR PHARMACEUTICALS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 92 ROW: MARKET SIZE FOR RESEARCH & BIOTECHNOLOGY, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 93 ROW: MARKET SIZE FOR DIAGNOSTICS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 94 ROW: MARKET SIZE FOR BIOCATALYSTS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 95 ROW: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 96 ROW: MARKET SIZE, BY TYPE, 2017–2025 (TON)
TABLE 97 ROW: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 98 ROW: ENZYMES MARKET SIZE, BY SOURCE, 2017–2025 (USD MILLION)
TABLE 99 BRAZIL: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 100 BRAZIL: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION) 123
TABLE 101 ARGENTINA: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 102 ARGENTINA: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 103 SOUTH AFRICA: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 104 SOUTH AFRICA: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 105 OTHERS IN ROW: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 106 OTHERS IN ROW: SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 107 EXPANSIONS & INVESTMENTS, 2017–2019
TABLE 108 AGREEMENTS, COLLABORATIONS, AND JOINT VENTURES, 2017–2019
TABLE 109 NEW PRODUCT LAUNCHES, 2017–2019
TABLE 110 ACQUISITIONS, 2017–2019


LIST OF FIGURES (53 Figures)

FIGURE 1 MARKET SEGMENTATION
FIGURE 2 SPECIALTY ENZYMES MARKET: RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY VALUE CHAIN, DESIGNATION, AND REGION
FIGURE 4 GDP GROWTH OF KEY ECONOMIES, 2013–2018 (USD TRILLION)
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2019 VS. 2025 (USD MILLION)
FIGURE 8 MARKET SIZE, BY TYPE, 2019 VS. 2025 (TON)
FIGURE 9 MARKET SIZE, BY APPLICATION, 2019 VS. 2025 (USD MILLION)
FIGURE 10 MARKET SIZE, BY SOURCE, 2019 VS. 2025 (USD MILLION)
FIGURE 11 MARKET SHARE (VALUE), BY REGION, 2018
FIGURE 12 GROWING DEMAND FOR PHARMACEUTICAL PRODUCTS IS PROJECTED TO DRIVE THE GROWTH OF THE MARKET
FIGURE 13 US WAS THE LARGEST MARKET GLOBALLY FOR SPECIALTY ENZYMES IN 2018
FIGURE 14 US ACCOUNTED FOR THE LARGEST SHARE IN THE NORTH AMERICAN MARKET IN 2018
FIGURE 15 NORTH AMERICA IS PROJECTED TO DOMINATE THE MARKET FOR SPECIALTY ENZYMES, 2019 VS. 2025
FIGURE 16 THE PHARMACEUTICALS SEGMENT IS PROJECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD, 2019 VS. 2025
FIGURE 17 MARKET: VALUE CHAIN
FIGURE 18 MARKET DYNAMICS
FIGURE 19 FOOD DIAGNOSTICS MARKET SIZE, BY REGION, 2016–2023 (USD BILLION)
FIGURE 20 INDIA: REVENUE OF THE PHARMACEUTICAL SECTOR, 2016–2019 (USD BILLION)
FIGURE 21 GLOBAL EXPENDITURE ON R&D, 2015–2018 (USD MILLION)
FIGURE 22 PATENT INSIGHTS
FIGURE 23 SPECIALTY ENZYMES MARKET SHARE (VALUE), BY TYPE, 2019 VS. 2025
FIGURE 24 MARKET SHARE (VALUE), BY APPLICATION, 2019 VS. 2025
FIGURE 25 MARKET SHARE (VALUE), BY SOURCE, 2019 VS. 2025
FIGURE 26 FLOW CHART FOR THE PRODUCTION OF DRY ENZYMES
FIGURE 27 SPECIALTY ENZYMES MARKET GROWTH, BY KEY COUNTRY, 2019–2025
FIGURE 28 NORTH AMERICA: SPECIALTY ENZYMES MARKET SNAPSHOT
FIGURE 29 EUROPE: SPECIALTY ENZYMES MARKET SNAPSHOT, 2018
FIGURE 30 ASIA PACIFIC: SPECIALTY ENZYMES MARKET SNAPSHOT
FIGURE 31 SPECIALTY ENZYMES MARKET (OVERALL MARKET): COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 32 BASF LED THE SPECIALTY ENZYMES MARKET IN 2018
FIGURE 33 PRODUCT PORTFOLIO ANALYSIS OF TOP PLAYERS IN (OVERALL MARKET) SPECIALTY ENZYMES MARKET
FIGURE 34 BUSINESS STRATEGY EXCELLENCE OF TOP PLAYERS IN (OVERALL MARKET) MARKET
FIGURE 35 SPECIALTY ENZYMES MARKET (START-UP/SME): COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 36 PRODUCT PORTFOLIO ANALYSIS OF TOP PLAYERS IN (STARTUP/SME) SPECIALTY ENZYMES MARKET
FIGURE 37 BUSINESS STRATEGY EXCELLENCE OF TOP PLAYERS IN (STARTUP/SME) SPECIALTY ENZYMES MARKET
FIGURE 38 BASF: COMPANY SNAPSHOT
FIGURE 39 BASF: SWOT ANALYSIS
FIGURE 40 NOVOZYMES: COMPANY SNAPSHOT
FIGURE 41 NOVOZYMES: SWOT ANALYSIS
FIGURE 42 ROCHE HOLDING: COMPANY SNAPSHOT
FIGURE 43 ROCHE HOLDING: SWOT ANALYSIS
FIGURE 44 DUPONT: COMPANY SNAPSHOT
FIGURE 45 DUPONT: SWOT ANALYSIS
FIGURE 46 CODEXIS: COMPANY SNAPSHOT
FIGURE 47 CODEXIS: SWOT ANALYSIS
FIGURE 48 DYADIC INTERNATIONAL: COMPANY SNAPSHOT
FIGURE 49 ADVANCED ENZYMES: COMPANY SNAPSHOT
FIGURE 50 SANOFI: COMPANY SNAPSHOT
FIGURE 51 AMICOGEN: COMPANY SNAPSHOT
FIGURE 52 NAGASE & CO. LTD.: COMPANY SNAPSHOT
FIGURE 53 MERCK KGAA: COMPANY SNAPSHOT

The study involved four major activities in estimating the market size for the specialty enzymes market. Exhaustive secondary research was conducted to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources, such as Hoovers, Bloomberg BusinessWeek, and Dun & Bradstreet, were referred to, to identify and collect information for this study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold & silver standard websites, regulatory bodies, trade directories, and databases.

Primary Research

The market comprises several stakeholders, such as raw material suppliers, processors, end-product manufacturers, and regulatory organizations in the supply chain. The demand-side of the market is characterized by the presence of enzyme manufacturing companies and government organizations, service providing company officials, government and research organizations, and research officers. The supply-side is characterized by the presence of key CEOs and vice presidents, marketing directors, product innovation directors and related key executives from manufacturing companies and organizations operating in the market, and manufacturing and marketing companies. Various primary sources from both the supply- and demand sides of the market were interviewed to obtain qualitative and quantitative information.

Given below is the breakdown of the primary respondents.

Specialty Enzymes Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both the top-down and bottom-up approaches were used to estimate and validate the total size of the specialty enzymes market. These methods were also used extensively to determine the size of various subsegments in the market. The research methodology used to estimate the market size include the following:

  • The key players were identified through extensive primary and secondary research.
  • The value chain and market size of the specialty enzymes market, in terms of value, were determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
  • All possible parameters that affect the market covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.
  • The research included the study of reports, reviews, newsletters of top market players, along with extensive interviews for opinions from key leaders, such as CEOs, directors, and marketing executives.

Data Triangulation

After arriving at the overall market size from the estimation process described above, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides. In addition, the market size was validated using both top-down and bottom-up approaches. It was then verified through primary interviews. Hence, three approaches were adopted-top-down approach, bottom-up approach, and the one involving expert interviews. Only when the values arrived at from the three points match, the data is assumed to be correct.

Report Objectives

  • To describe and forecast the specialty enzymes market, in terms of type, source, application, form, and region
  • To describe and forecast the market for specialty enzymes, in terms of value, by region–North America, Europe, Asia Pacific, and the Rest of the World—along with their respective countries
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To study the complete value chain of the market
  • To analyze opportunities in the market for stakeholders by identifying the high-growth segments of the specialty enzymes market
  • To strategically profile the key players and comprehensively analyze their market positions, in terms of ranking and core competencies, along with details on the competitive landscape of market leaders
  • To analyze strategic approaches, such as acquisitions & divestments, expansions, product launches & approvals, and agreements, in the market

Available Customizations

Based on the given market data, MarketsandMarkets offers customizations in the reports according to client-specific requirements. The available customization options are as follows:

Geographic Analysis

  • Further breakdown of the Rest of the World of specialty enzymes market into Brazil, Argentina South Africa, and RoW (Nigeria, Kenya, Ethiopia, Tanzania, Morocco, Egypt, and the Democratic Republic of Congo)
  • Further breakdown of the Rest of Europe for specialty enzymes market into Poland, Belgium, Sweden, and other EU & non-EU countries

Segment Analysis

  • Further breakdown of the application segment into major countries
Report Code
FB 2276
Published ON
Apr, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Specialty Enzymes Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home